Unleashing Tumour-Dendritic Cells to Fight Cancer by Tackling Their Three A’s: Abundance, Activation and Antigen-Delivery

por Murgaski, Aleksandar, Bardet, Pauline M. R., Arnouk, Sana M., Clappaert, Emile J., Laoui, Damya
Publicado 2019

Innate Immune Defense Mechanisms by Myeloid Cells That Hamper Cancer Immunotherapy

por Lebegge, Els, Arnouk, Sana M., Bardet, Pauline M. R., Kiss, Máté, Raes, Geert, Van Ginderachter, Jo A.
Publicado 2020

Flt3L therapy increases the abundance of Treg-promoting CCR7(+) cDCs in preclinical cancer models

por Clappaert, Emile J., Kancheva, Daliya, Brughmans, Jan, Debraekeleer, Ayla, Bardet, Pauline M. R., Elkrim, Yvon, Lacroix, Dagmar, Živalj, Maida, Hamouda, Ahmed E.I., Van Ginderachter, Jo A., Deschoemaeker, Sofie, Laoui, Damya
Publicado 2023

Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironment

por Kiss, Máté, Lebegge, Els, Murgaski, Aleksandar, Van Damme, Helena, Kancheva, Daliya, Brughmans, Jan, Scheyltjens, Isabelle, Talebi, Ali, Awad, Robin Maximilian, Elkrim, Yvon, Bardet, Pauline M. R., Arnouk, Sana M., Goyvaerts, Cleo, Swinnen, Johan, Nana, Frank Aboubakar, Van Ginderachter, Jo A., Laoui, Damya
Publicado 2022